Sav1 Loss Induces Senescence and Stat3 Activation Coinciding with Tubulointerstitial Fibrosis

REFERENCES

• LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. 2013. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19:1047–1053. https://doi.org/10.1038/nm.3218.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. 2010. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21:1819–1834. https://doi.org/10.1681/ASN.2010080793.
   PubMed Web of Science ®Google Scholar
• Edeling M, Ragi G, Huang S, Pavenstadt H, Susztak K. 2016. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol 12:426–439. https://doi.org/10.1038/nrneph.2016.54.
   PubMed Web of Science ®Google Scholar
• Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA. 2006. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 25:5603–5613. https://doi.org/10.1038/sj.emboj.7601421.
   PubMed Web of Science ®Google Scholar
• Grande MT, Sanchez-Laorden B, Lopez-Blau C, De Frutos CA, Boutet A, Arevalo M, Rowe RG, Weiss SJ, Lopez-Novoa JM, Nieto MA. 2015. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 21:989–997. https://doi.org/10.1038/nm.3901.
   PubMed Web of Science ®Google Scholar
• Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, Nischal H, Allison JP, Zeisberg M, Kalluri R. 2015. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21:998–1009. https://doi.org/10.1038/nm.3902.
   PubMed Web of Science ®Google Scholar
• Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C. 2003. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 14:1132–1144. https://doi.org/10.1097/01.ASN.0000060574.38107.3B.
   PubMed Web of Science ®Google Scholar
• Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, Chatziantoniou C. 2009. Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin. PLoS One 4:e6721. https://doi.org/10.1371/journal.pone.0006721.
   Google Scholar
• Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C. 2013. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents. Hypertension 61:901–907. https://doi.org/10.1161/HYPERTENSIONAHA.111.00639.
   PubMedGoogle Scholar
• Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R. 2009. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361:40–51. https://doi.org/10.1056/NEJMoa0808400.
   PubMed Web of Science ®Google Scholar
• Musso G, Cassader M, Cohney S, De Michieli F, Pinach S, Saba F, Gambino R. 2016. Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities. Diabetes Care 39:1830–1845. https://doi.org/10.2337/dc15-1182.
   PubMed Web of Science ®Google Scholar
• Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Pare G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tonjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, Feitosa M, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N, Meisinger C, Wichmann HE, Koenig W, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstätter A, Kollerits B, Kedenko L, Mägi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Völzke H, Kroemer HK, Nauck M, Völker U, Polasek O, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Krämer BK, Rudan I, Gyllensten U, Wilson JF, Witteman JC, Pramstaller PP, Rettig R, Hastie N, Chasman DI, Kao WH, Heid IM, Fox CS. 2010. New loci associated with kidney function and chronic kidney disease. Nat Genet 42:376–384. https://doi.org/10.1038/ng.568.
   PubMed Web of Science ®Google Scholar
• Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Kawaguchi T, Stahl EA, Kurreeman FA, Nishida N, Ohmiya H, Myouzen K, Takahashi M, Sawada T, Nishioka Y, Yukioka M, Matsubara T, Wakitani S, Teshima R, Tohma S, Takasugi K, Shimada K, Murasawa A, Honjo S, Matsuo K, Tanaka H, Tajima K, Suzuki T, Iwamoto T, Kawamura Y, Tanii H, Okazaki Y, Sasaki T, Gregersen PK, Padyukov L, Worthington J, Siminovitch KA, Lathrop M, Taniguchi A, Takahashi A, Tokunaga K, Kubo M, Nakamura Y, Kamatani N, Mimori T, Plenge RM, Yamanaka H, Momohara S, Yamada R, Matsuda F, Yamamoto K. 2012. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 44:511–516. https://doi.org/10.1038/ng.2231.
   PubMed Web of Science ®Google Scholar
• Chan SW, Lim CJ, Chen L, Chong YF, Huang C, Song H, Hong W. 2011. The hippo pathway in biological control and cancer development. J Cell Physiol 226:928–939. https://doi.org/10.1002/jcp.22435.
   PubMed Web of Science ®Google Scholar
• Pan D. 2010. The Hippo signaling pathway in development and cancer. Dev Cell 19:491–505. https://doi.org/10.1016/j.devcel.2010.09.011.
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Lei Q, Guan KL. 2010. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24:862–874. https://doi.org/10.1101/gad.1909210.
   PubMed Web of Science ®Google Scholar
• Ziosi M, Baena-López LA, Grifoni D, Froldi F, Pession A, Garoia F, Trotta V, Bellosta P, Cavicchi S, Pession A. 2010. dMyc functions downstream of Yorkie to promote the supercompetitive behavior of Hippo pathway mutant cells. PLoS Genet 6:e1001140. https://doi.org/10.1371/journal.pgen.1001140.
   Google Scholar
• Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C, Inui M, Montagner M, Parenti Anna R, Poletti A, Daidone Maria G, Dupont S, Basso G, Bicciato S, Piccolo S. 2011. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147:759–772. https://doi.org/10.1016/j.cell.2011.09.048.
   PubMed Web of Science ®Google Scholar
• Nicolay BN, Bayarmagnai B, Islam ABMMK, Lopez-Bigas N, Frolov MV. 2011. Cooperation between dE2F1 and Yki/Sd defines a distinct transcriptional program necessary to bypass cell cycle exit. Genes Dev 25:323–335. https://doi.org/10.1101/gad.1999211.
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Wang L, Wang CY, Yu J, Guan KL. 2012. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26:54–68. https://doi.org/10.1101/gad.173435.111.
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21:2747–2761. https://doi.org/10.1101/gad.1602907.
   PubMed Web of Science ®Google Scholar
• Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang Y, Halder G, Finegold MJ, Lee JS, Johnson RL. 2010. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107:1437–1442. https://doi.org/10.1073/pnas.0911427107.
   PubMed Web of Science ®Google Scholar
• Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. 2005. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65:7561–7567.
   PubMedGoogle Scholar
• Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G. 2006. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223–5233. https://doi.org/10.1200/JCO.2006.06.3701.
   PubMed Web of Science ®Google Scholar
• Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC, Albertson DG. 2005. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24:4232–4242. https://doi.org/10.1038/sj.onc.1208601.
   PubMed Web of Science ®Google Scholar
• Yokoyama T, Osada H, Murakami H, Tatematsu Y, Taniguchi T, Kondo Y, Yatabe Y, Hasegawa Y, Shimokata K, Horio Y, Hida T, Sekido Y. 2008. YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation. Carcinogenesis 29:2139–2146. https://doi.org/10.1093/carcin/bgn200.
   PubMed Web of Science ®Google Scholar
• Liu F, Lagares D, Choi KM, Stopfer L, Marinkovic A, Vrbanac V, Probst CK, Hiemer SE, Sisson TH, Horowitz JC, Rosas IO, Fredenburgh LE, Feghali-Bostwick C, Varelas X, Tager AM, Tschumperlin DJ. 2015. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol 308:L344–L357. https://doi.org/10.1152/ajplung.00300.2014.
   PubMed Web of Science ®Google Scholar
• Mannaerts I, Leite SB, Verhulst S, Claerhout S, Eysackers N, Thoen LF, Hoorens A, Reynaert H, Halder G, van Grunsven LA. 2015. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. J Hepatol 63:679–688. https://doi.org/10.1016/j.jhep.2015.04.011.
   PubMed Web of Science ®Google Scholar
• McNeill H, Reginensi A. 2017. Lats1/2 regulate Yap/Taz to control nephron progenitor epithelialization and inhibit myofibroblast formation. J Am Soc Nephrol 28:852–861. https://doi.org/10.1681/ASN.2016060611.
   PubMed Web of Science ®Google Scholar
• Seo E, Kim WY, Hur J, Kim H, Nam SA, Choi A, Kim YM, Park SH, Chung C, Kim J, Min S, Myung SJ, Lim DS, Kim YK. 2016. The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis. Sci Rep 6:31931. https://doi.org/10.1038/srep31931.
   PubMedGoogle Scholar
• Lantinga-van Leeuwen IS, Leonhard WN, van de Wal A, Breuning MH, Verbeek S, de Heer E, Peters DJ. 2006. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells. Genesis 44:225–232. https://doi.org/10.1002/dvg.20207.
   PubMedGoogle Scholar
• Bottinger EP, Bitzer M. 2002. TGF-beta signaling in renal disease. J Am Soc Nephrol 13:2600–2610. https://doi.org/10.1097/01.ASN.0000033611.79556.AE.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. 2016. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 12:325–338. https://doi.org/10.1038/nrneph.2016.48.
   PubMed Web of Science ®Google Scholar
• Kang HM, Ahn SH, Choi P, Ko YA, Han SH, Chinga F, Park AS, Tao J, Sharma K, Pullman J, Bottinger EP, Goldberg IJ, Susztak K. 2015. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med 21:37–46. https://doi.org/10.1038/nm.3762.
   PubMed Web of Science ®Google Scholar
• Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfarb J, Horne FM, Kimmel PL, Molitoris BA, Murthy M, O'Hare AM, Schmader KE, High KP. 2011. Acute kidney injury in older adults. J Am Soc Nephrol 22:28–38. https://doi.org/10.1681/ASN.2010090934.
   PubMed Web of Science ®Google Scholar
• Grams ME, Chow EK, Segev DL, Coresh J. 2013. Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis 62:245–252. https://doi.org/10.1053/j.ajkd.2013.03.009.
   PubMed Web of Science ®Google Scholar
• Rosner MH. 2013. Acute kidney injury in the elderly. Clin Geriatr Med 29:565–578. https://doi.org/10.1016/j.cger.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Yang HC, Fogo AB. 2014. Fibrosis and renal aging. Kidney Int Suppl (2011) 4:75–78. https://doi.org/10.1038/kisup.2014.14.
   PubMed Web of Science ®Google Scholar
• Childs BG, Durik M, Baker DJ, van Deursen JM. 2015. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21:1424–1435. https://doi.org/10.1038/nm.4000.
   PubMed Web of Science ®Google Scholar
• Kim WY, Sharpless NE. 2006. The regulation of INK4/ARF in cancer and aging. Cell 127:265–275. https://doi.org/10.1016/j.cell.2006.10.003.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, Sharpless NE. 2004. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:1299–1307. https://doi.org/10.1172/JCI22475.
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. 2013. The hallmarks of aging. Cell 153:1194–1217. https://doi.org/10.1016/j.cell.2013.05.039.
   PubMed Web of Science ®Google Scholar
• Clements ME, Chaber CJ, Ledbetter SR, Zuk A. 2013. Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One 8:e70464. https://doi.org/10.1371/journal.pone.0070464.
   Google Scholar
• DiRocco DP, Bisi J, Roberts P, Strum J, Wong KK, Sharpless N, Humphreys BD. 2014. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. Am J Physiol Renal Physiol 306:F379–F388. https://doi.org/10.1152/ajprenal.00475.2013.
   PubMed Web of Science ®Google Scholar
• Ferenbach DA, Bonventre JV. 2015. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol 11:264–276. https://doi.org/10.1038/nrneph.2015.3.
   PubMed Web of Science ®Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51. https://doi.org/10.1038/36285.
   PubMed Web of Science ®Google Scholar
• Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M. 2005. Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833. https://doi.org/10.1126/science.1112766.
   PubMed Web of Science ®Google Scholar
• Sato S, Kawamata Y, Takahashi A, Imai Y, Hanyu A, Okuma A, Takasugi M, Yamakoshi K, Sorimachi H, Kanda H, Ishikawa Y, Sone S, Nishioka Y, Ohtani N, Hara E. 2015. Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice. Nat Commun 6:7035. https://doi.org/10.1038/ncomms8035.
   PubMedGoogle Scholar
• Satoh M, Nagasu H, Morita Y, Yamaguchi TP, Kanwar YS, Kashihara N. 2012. Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling. Am J Physiol Renal Physiol 303:F1641–F1651. https://doi.org/10.1152/ajprenal.00460.2012.
   PubMed Web of Science ®Google Scholar
• Debelle FD, Vanherweghem JL, Nortier JL. 2008. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74:158–169. https://doi.org/10.1038/ki.2008.129.
   PubMed Web of Science ®Google Scholar
• Susnik N, Sorensen-Zender I, Rong S, von Vietinghoff S, Lu X, Rubera I, Tauc M, Falk CS, Alexander WS, Melk A, Haller H, Schmitt R. 2014. Ablation of proximal tubular suppressor of cytokine signaling 3 enhances tubular cell cycling and modifies macrophage phenotype during acute kidney injury. Kidney Int 85:1357–1368. https://doi.org/10.1038/ki.2013.525.
   PubMedGoogle Scholar
• Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853–2868. https://doi.org/10.1371/journal.pbio.0060301.
   PubMed Web of Science ®Google Scholar
• Chai EZ, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LH, Wang L, Goh BC, Ahn KS, Hui KM, Sethi G. 2016. Targeting transcription factor STAT3 for cancer prevention and therapy. Pharmacol Ther 162:86–97. https://doi.org/10.1016/j.pharmthera.2015.10.004.
   PubMed Web of Science ®Google Scholar
• Chuang PY, He JC. 2010. JAK/STAT signaling in renal diseases. Kidney Int 78:231–234. https://doi.org/10.1038/ki.2010.158.
   PubMedGoogle Scholar
• Bienaime F, Muorah M, Yammine L, Burtin M, Nguyen C, Baron W, Garbay S, Viau A, Broueilh M, Blanc T, Peters D, Poli V, Anglicheau D, Friedlander G, Pontoglio M, Gallazzini M, Terzi F. 2016. Stat3 controls tubulointerstitial communication during CKD. J Am Soc Nephrol 27:3690–3705. https://doi.org/10.1681/ASN.2015091014.
   PubMedGoogle Scholar
• Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA, Hariharan IK. 2002. salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110:467–478. https://doi.org/10.1016/S0092-8674(02)00824-3.
   PubMed Web of Science ®Google Scholar
• Wu S, Huang J, Dong J, Pan D. 2003. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114:445–456. https://doi.org/10.1016/S0092-8674(03)00549-X.
   PubMed Web of Science ®Google Scholar
• Piersma B, Bank RA, Boersema M. 2015. Signaling in fibrosis: TGF-beta, WNT, and YAP/TAZ converge. Front Med (Lausanne) 2:59. https://doi.org/10.3389/fmed.2015.00059.
   PubMed Web of Science ®Google Scholar
• Xu J, Li PX, Wu J, Gao YJ, Yin MX, Lin Y, Yang M, Chen DP, Sun HP, Liu ZB, Gu XC, Huang HL, Fu LL, Hu HM, He LL, Wu WQ, Fei ZL, Ji HB, Zhang L, Mei CL. 2016. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector. Clin Sci (Lond) 130:349–363. https://doi.org/10.1042/CS20150385.
   PubMedGoogle Scholar
• Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D. 2012. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 26:1300–1305. https://doi.org/10.1101/gad.192856.112.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ramakrishnan SK, Triner D, Centofanti B, Maitra D, Gyorffy B, Sebolt-Leopold JS, Dame MK, Varani J, Brenner DE, Fearon ER, Omary MB, Shah YM. 2015. Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Sci Signal 8:ra98. https://doi.org/10.1126/scisignal.aac5418.
   PubMedGoogle Scholar
• Kai T, Tsukamoto Y, Hijiya N, Tokunaga A, Nakada C, Uchida T, Daa T, Iha H, Takahashi M, Nomura T, Sato F, Mimata H, Ikawa M, Seto M, Matsuura K, Moriyama M. 2016. Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway. J Pathol 239:97–108. https://doi.org/10.1002/path.4706.
   PubMed Web of Science ®Google Scholar
• Matsuura K, Nakada C, Mashio M, Narimatsu T, Yoshimoto T, Tanigawa M, Tsukamoto Y, Hijiya N, Takeuchi I, Nomura T, Sato F, Mimata H, Seto M, Moriyama M. 2011. Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma. BMC Cancer 11:523. https://doi.org/10.1186/1471-2407-11-523.
   PubMedGoogle Scholar
• Donninger H, Allen N, Henson A, Pogue J, Williams A, Gordon L, Kassler S, Dunwell T, Latif F, Clark GJ. 2011. Salvador protein is a tumor suppressor effector of RASSF1A with Hippo pathway-independent functions. J Biol Chem 286:18483–18491. https://doi.org/10.1074/jbc.M110.214874.
   PubMedGoogle Scholar
• Szeto SG, Narimatsu M, Lu M, He X, Sidiqi AM, Tolosa MF, Chan L, De Freitas K, Bialik JF, Majumder S, Boo S, Hinz B, Dan Q, Advani A, John R, Wrana JL, Kapus A, Yuen DA. 2016. YAP/TAZ are mechanoregulators of TGF-β-Smad signaling and renal fibrogenesis. J Am Soc Nephrol 27:3117–3128. https://doi.org/10.1681/ASN.2015050499.
   PubMed Web of Science ®Google Scholar
• Sugiura H, Yoshida T, Shiohira S, Kohei J, Mitobe M, Kurosu H, Kuro-o M, Nitta K, Tsuchiya K. 2012. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol 302:F1252–F1264. https://doi.org/10.1152/ajprenal.00294.2011.
   PubMedGoogle Scholar
• Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL, He X, Mieczkowski P, Grimm SA, Perou CM, MacLeod JN, Chiang DY, Prins JF, Liu J. 2010. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 38:e178. https://doi.org/10.1093/nar/gkq622.
   PubMed Web of Science ®Google Scholar
• Li B, Dewey CN. 2011. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12:323. https://doi.org/10.1186/1471-2105-12-323.
   PubMed Web of Science ®Google Scholar
• Bullard JH, Purdom E, Hansen KD, Dudoit S. 2010. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics 11:94. https://doi.org/10.1186/1471-2105-11-94.
   PubMed Web of Science ®Google Scholar